川崎病后巨大冠状动脉瘤的结局:美国单中心经验
该单中心回顾性队列纳入1989至2023年60例川崎病合并巨大冠状动脉瘤患者,中位随访11年。21.7%发生主要不良心血管事件(MACE),10/20/30年无MACE率分别为75%/75%/60%;26.7%冠状动脉瘤消退至正常管径。双侧冠状动脉瘤或最大Z值≥20者更易发生MACE。
要点
- 巨大冠状动脉瘤患者约22%发生MACE,双侧或Z值≥20者风险更高。
- 10/20/30年无MACE率分别为75%/75%/60%。
- 26.7%的巨大冠状动脉瘤可消退至正常管径,仍需长期心脏监测。
核心结论
- 川崎病合并巨大冠状动脉瘤患者长期MACE发生率近22%,双侧冠状动脉瘤或最大Z值≥20者更易发生MACE。
- 尽管超过25%的巨大冠状动脉瘤消退至正常管径,患者仍需长期心脏并发症监测。
研究设计与样本
- 美国单中心回顾性队列研究,纳入1989至2023年60例川崎病合并巨大冠状动脉瘤患者,中位随访11年(最长34.5年)。
主要发现
- 60例患者中男性占71.7%,诊断时中位年龄0.9岁(范围0.2-13.3岁)。
- 13例(21.7%)发生MACE,MACE发生于川崎病诊断后中位1.4年(范围0.04-22.6年)。
- 10年、20年、30年无MACE率分别为75%、75%、60%。
- 26.7%的冠状动脉瘤消退至正常管径,消退发生于中位3.6年(范围0.6-12.0年)。
- 10年、20年、30年冠状动脉瘤消退至正常管径的可能性分别为36%、46%、46%。
关键数值与推荐
- 最大冠状动脉Z值≥20或双侧冠状动脉瘤的患者更易发生MACE。
临床怎么用
- 对有巨大冠状动脉瘤病史的川崎病患者,即使冠状动脉瘤消退至正常管径,仍需长期监测心脏并发症。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To determine the long-term outcomes among a cohort of patients with Kawasaki disease (KD) and a history of giant coronary artery aneurysms (CAAs) at a single US center. STUDY DESIGN: Medical records for all patients with KD and giant CAAs at a pediatric academic institution were reviewed. Primary outcomes included major adverse cardiovascular events (MACE) and normalization of CA luminal diameter, using Kaplan-Meier analyses. RESULTS: There were 60 patients with KD and giant CAAs identified between 1989 and 2023. The majority of patients were male (71.7%) with a median age at diagnosis of 0.9 years (range, 0.2-13.3 years). Patients were followed for a median of 11 years, up to 34.5 years. MACE occurred in 13 patients (21.7%) at a median of 1.4 years (range, 0.04-22.6 years) after KD diagnosis. The 10-, 20-, and 30-year MACE-free rates were 75%, 75%, and 60%. Patients with maximal CA z scores of ≥20 or bilateral CAA were more likely to have MACE. During follow-up, 26.7% of CAA regressed to a normal luminal diameter at a median of 3.6 years (range, 0.6-12.0 years). The 10-, 20- and 30-year likelihood of CA regression to normal luminal diameter was 36%, 46%, and 46%. CONCLUSIONS: Over 30 years, MACE occurred in nearly 22% of patients, more often in those with bilateral CAA or CA z scores of ≥20. Despite regression to a normal luminal diameter in >25% of CAAs, patients with a history of KD-associated giant CAA require ongoing surveillance for cardiac complications, even years after the initial disease.
引用
- Elias MD, Brothers JA, Hogarty AN, et al. Outcomes Associated with Giant Coronary Artery Aneurysms after Kawasaki Disease: A Single-Center United States Experience. J Pediatr. 2024. PMID: 38878963. doi:10.1016/j.jpeds.2024.114145
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。